Overview

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Status:
Completed
Trial end date:
2014-04-09
Target enrollment:
Participant gender:
Summary
Evaluate the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) ETI-204 alone and in the presence of IV and oral ciprofloxacin
Phase:
Phase 1
Details
Lead Sponsor:
Elusys Therapeutics
Treatments:
Ciprofloxacin